Global Chondroplasty Market Report 2025: Market Opportunities & Challenges Outlook

 Tailored for companies operating in or entering the chondroplasty sector, this analysis highlights core growth drivers, risks, and innovation trends.

 

 What Is The Current Outlook For The Chondroplasty Market?
 The chondroplasty market size has grown strongly in recent years. It will grow from $13.77 billion in 2024 to $14.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increased sports-related injuries, patient preference for non-total joint replacement, postoperative care advances, healthcare provider training and expertise, increasing incidence of joint disorders.
 
 The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $18.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to regenerative medicine integration, focus on outpatient procedures, introduction of novel biomaterials, rise in musculoskeletal disorders, expansion of geriatric population. Major trends in the forecast period include technological integration in rehabilitation, arthroscopic techniques, cartilage repair and regeneration, technological innovations in surgical tools, integration of navigation systems.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=13185&type=smp
 
 What Are The Driving Factors Impacting The Chondroplasty Market?
 The rising incidence of joint-related disorders is expected to propel the growth of the chondroplasty market going forward. Joint disorders are diseases that affect the health and function of a joint caused by overuse of a joint or a sudden injury, such as an accident or a sports injury. Chondroplasty treats joint-related disorders by repairing the damaged cartilage in a joint. For instance, in August 2023, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, the incidence of gout, an inflammatory arthritis affecting joints, rose from 1.40 diagnoses per 1,000 adults in March 2021 to 1.44 diagnoses per 1,000 adults in March 2022 in the UK. Therefore, the rising incidence of joint-related disorders is driving the growth of the chondroplasty market going forward.
 
 Analysis Of Major Segments Driving The Chondroplasty Market Growth
 The chondroplastymarket covered in this report is segmented — 
 
 1) By Type: Radiofrequency Ablation Chondroplasty; Abrasion Chondroplasty; Atellar Chondroplasty; Meniscal Repair; Tissue Removal; Other Types
 2) By Anatomy: Knee; Shoulder; Hip; Other Anatomies
 3) By Equipment: Shavers; Radiofrequency Devices; Arthroscope; Other Equipments
 4) By End Use: Hospitals; Orthopedic Clinics; Academic Research; Other End Uses
 
 Subsegments:
 1) By Radiofrequency Ablation Chondroplasty: High-Frequency Ablation; Low-Frequency Ablation 
 2) By Abrasion Chondroplasty: Mechanical Abrasion; Arthroscopic Abrasion 
 3) By Patellar Chondroplasty: Open Patellar Chondroplasty; Arthroscopic Patellar Chondroplasty 
 4) By Meniscal Repair: Suturing Techniques; Meniscal Allograft Transplantation 
 5) By Tissue Removal: Arthroscopic Debridement; Open Debridement 
 6) By Other Types: Microfracture Techniques; Osteochondral Autograft Transplantation 
 
 Emerging Trends And Strategic Opportunities In The Chondroplasty Market
 Major companies operating in the chondroplasty market are developing autologous chondrocytes to enhance cartilage repair by utilizing the patient’s own cells, which reduces immune rejection and promotes natural regeneration. Autologous chondrocytes are cartilage cells taken from a patient’s own body, typically harvested from a non-weight-bearing area of the joint. For instance, in August 2024, Vericel Corporation, a US-based biopharmaceutical company, received FDA approval and commercial availability of MACI Arthro (Matrix Autologous Chondrocyte Implantation), a significant advancement in the treatment of cartilage defects in the knee. MACI Arthro allows orthopedic surgeons to perform the procedure through small incisions using specially designed instruments, which is less invasive compared to traditional methods. This approach is expected to enhance patient recovery and reduce post-operative complications. 
 
 Which Are The Top Players Involved In Chondroplasty Market?
 Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.
 
 View the full chondroplasty market report here:
 https://www.thebusinessresearchcompany.com/report/chondroplasty-global-market-report
 
 Which Region Drives The Most Demand In The Chondroplasty Market?
 North America was the largest region in the chondroplasty market in 2024. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company